median age 50 years, 72% women) were no longer taking it after one year -- with 18%, 31% and 42% stopping treatment within 3, 6 and 9 months, respectively
All experimental procedures involving animals were conducted following international recommendations for the care and use of laboratory animals, as well as the guidelines of the Brazilian Society of Neurosciences and Behavior for Animal Care
Editors Note: Nurse Approved reached out to obesity medicine experts, nurse practitioners, and healthcare leaders for additional perspective on the clinical and ethical considerations surrounding investigational weight-loss therapies
A significant side effect of GLP-1s is weight loss
Never use a 1 mL syringe with 60 mg/mL tirzepatide, because the markings are too far apart to distinguish between doses that differ by several milligrams
Anti-gas measures like simethicone and dietary modification reduce the fermentation component